pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Senate advances Erica Schwartz’s CDC director nomination to full Senate vote

Jul 31, 2026·read at STAT ↗RegulatoryNeutral

The Senate Health Committee approved Erica Schwartz as the nominee for CDC director, securing bipartisan support that included every Republican member and Democrat Tim Kaine.

With the committee’s endorsement, her nomination now moves to the full Senate floor, where confirmation is expected.

The panel also approved Sean Kaufman as the pandemic‑preparedness leader after Senator Bill Cassidy set aside his reservations and backed the Trump‑administration pick.

These appointments are presented as steps to improve the nation’s infectious‑disease monitoring and pandemic readiness.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Federal government could improve infectious disease monitoring, says federal government”

read at STAT ↗
1,166 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2Vera Therapeutics, Inc.
drugs
Rare Disease2
topics
Infectious Disease4Vaccine4Drug Shortage3Psychiatry & CNS3Rare Disease2RecallType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 4d agoA trend that isn’t fading, ultra-processed baby foodsSTAT
  • Jul 8Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsSTAT
  • Jun 10DOJ reaches second settlement on youth gender careSTAT
  • 6h agoSyphilis spreads while researchers contend with federal constraints and a drug shortageSTAT